SlideShare a Scribd company logo
THE ROLE OF IMMUNE SYSTEM
IN THE EPIDEMIOLOGY AND
CONTROL OF TUBERCULOSIS
BY
ADAMS SADIAT HALIMAT
20HSM033
 Epidemiology is the branch of medicine which
deals with the incidence, distribution, and
possible control of diseases and other factors
relating to health.
 Tuberculosis is a potentially serious infectious
disease that mainly affects the lungs.
19th century peak incidence in western Europe and
North America
1882 - M. tuberculosis identificated by Koch
1920 - „sanatorium regimen“, collapse therapy,
thoracoplasty
1960 - chemotherapy
Introduction
• acid (alcohol, alkalis)
fasteness
• slow rate of growth
• sensitive to heat and UV
irradiation
• nonmotile
• nonsporulating
1. Ischaemic heart disease 7.2 12.2
2. Cerebrovascular disease 5.7 9.7
3. Lower respiratory infections 4.2 7.1
4. COPD 3.0 5.1
5. Diarrhoeal diseases 2.2 3.7
6. HIV/AIDS 2.0 3.5
7. Tuberculosis 1.5 2.5
8. Trachea, bronchus, lung cancers 1.3 2.3
9. Road traffic accidents 1.3 2.2
10. Prematurity and low birth weight 1.2 2.0
Epidemiology
Exposure
• Living in the
household of a
tuberculosis case
• Immigration from an
endemic area (Asia,
Latin America)
• Exposure in
congregate living
facilities (jails, shelters,
health care facilities)
• Older age
• Residence in higher
incidence location
(inner cities)
Susceptibility
• HIV+ & PPD > 5 mm
• Drug users
• Close contacts of person known or suspected to
have TB, sharing the same household or other
enclosed enviroment & PPD > 5 mm
• Documented recent converters (PPD increase >
10 mm within 2 years for those under age 35 or
> 15 mm - 35 years old and over)
• Medical risk factors (+PPD > 10 mm):
– silicosis
– weight of 10% or more below ideal body
weight
– chronic renal failure
– diabetes mellitus
– prolonged corticosteroid therapy
– Persons from areas with high TB prevalence
< 35 years old + PPD > 10 mm
– Any skin test reactor less than 15 years old
(PPD > 10 mm)
Epidemiology
Group Annual risk of TB
HIV 3-10%
2-5%
2-4%
PPD Converters
Abnormal CXR
Diabetes mellitus 0,3%
No risk factor 0,01-0,1%
Epidemiology
• in patients without specific immunity
• phagocytosis by alveolar macrophages
• primary lesion (Ghon focus) - mid or lower lung
zones
• marked tendency to central liquefaction and
cellular breakdown
• spread through lymphatic to regional lymph
nodes - marked reaction
• spread into blood stream - possible settling
throughout body
Pathogenesis
lipoarabinomannan
complement
receptor
phagosome
•inhibition of Ca2+ signals
•blockage of recruitment
and assembly of fusion
mediating proteins
transport to lymph
nodes
dissemination by
blood stream
Primary infection
AM
lysosome
mannose receptor
• Cough
• Sputum (mucoid, mucopurulent)
• Haemoptysis
• Chest pain (pleural involvement,
mediastinal lymph nodes
enlargement)
Clinical
manifestation
• Fever (active, progressive disease,
inverse temperature chart)
• Night sweats
• Loss of appetite, weight loss
• Other symptoms: amenorhea, stool
disturbances, hoarseness,
arrhytmias, erythema nodosum,
phlyctenular conjuctivitis…
Clinical
manifestation
1. Ensure proper ventilation of the patients
2. Cover the mouth while sneezing or
coughing
3. Taking prescribed medicines – keep
regular follow up with the doctor
4. Report any side effects of the medicines
The study demonstrated role of immune system
in epidemiology and tuberculosis infection
control, Tuberculosis remains one of the most
deadly infectious diseases and has claimed
millions of lives for many years. While significant
progress has been made towards controlling the
global burden of TB over the past decade, more
efforts are still needed. Emerging issues such
as multi drug-resistance threatens to revert the
progress made regarding TB care and control
THANK YOU

More Related Content

Similar to ADAMS SADIAT HALIMAT (20HSM033).pptx

Imaging approach to common respiratory infections in immuno-compromised patie...
Imaging approach to common respiratory infections in immuno-compromised patie...Imaging approach to common respiratory infections in immuno-compromised patie...
Imaging approach to common respiratory infections in immuno-compromised patie...
DrRabirraWaktola
 
Bronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical studentsBronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical students
jamal turki
 
Tuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atTuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'at
HarrisonMbohe
 
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptxPERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
Priyanka Pai
 
TB hiv co infect
TB hiv co infectTB hiv co infect
TB hiv co infect
James Visser
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Dr. Ravi Prakash
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Aliakbar Mohammadi
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Dr Shahnawaz Shah
 
Sarcoidosis and IgG4
Sarcoidosis and IgG4Sarcoidosis and IgG4
Sarcoidosis and IgG4
ikramdr01
 
Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment
Austin Publishing Group
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
Yogasundaram Sasikumar
 
Pneumonia / Community Acquired Pneumonia
Pneumonia / Community Acquired Pneumonia Pneumonia / Community Acquired Pneumonia
Pneumonia / Community Acquired Pneumonia
Dr. Pawan Kumar B
 
CLINICAL CLASSIFICATION OF TUBECULOSIS
CLINICAL  CLASSIFICATION  OF TUBECULOSIS CLINICAL  CLASSIFICATION  OF TUBECULOSIS
CLINICAL CLASSIFICATION OF TUBECULOSIS
Manish Singh
 
Sarcoidosis
Sarcoidosis Sarcoidosis
Sarcoidosis
Abhinand RS
 
Vasculitis
VasculitisVasculitis
Vasculitis
mohammed abdulbast
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Ngk Sharma
 
Human Immunodeficiency Viru Sreal
Human Immunodeficiency Viru SrealHuman Immunodeficiency Viru Sreal
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
Koppala RVS Chaitanya
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Dr Adnan Sami
 
TB and sarcoidosis.pptx
TB and sarcoidosis.pptxTB and sarcoidosis.pptx
TB and sarcoidosis.pptx
mhmdon67
 

Similar to ADAMS SADIAT HALIMAT (20HSM033).pptx (20)

Imaging approach to common respiratory infections in immuno-compromised patie...
Imaging approach to common respiratory infections in immuno-compromised patie...Imaging approach to common respiratory infections in immuno-compromised patie...
Imaging approach to common respiratory infections in immuno-compromised patie...
 
Bronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical studentsBronchiectasis and pulmonary hypertension medical students
Bronchiectasis and pulmonary hypertension medical students
 
Tuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atTuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'at
 
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptxPERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
PERIO MEDICINE - LINK BETWEEN PERIODONTITIS AND SYSTEMIC INFECTIONS PRI.pptx
 
TB hiv co infect
TB hiv co infectTB hiv co infect
TB hiv co infect
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Sarcoidosis and IgG4
Sarcoidosis and IgG4Sarcoidosis and IgG4
Sarcoidosis and IgG4
 
Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment Austin Tuberculosis: Research & Treatment
Austin Tuberculosis: Research & Treatment
 
Mixed connective tissue disorder
Mixed connective tissue disorderMixed connective tissue disorder
Mixed connective tissue disorder
 
Pneumonia / Community Acquired Pneumonia
Pneumonia / Community Acquired Pneumonia Pneumonia / Community Acquired Pneumonia
Pneumonia / Community Acquired Pneumonia
 
CLINICAL CLASSIFICATION OF TUBECULOSIS
CLINICAL  CLASSIFICATION  OF TUBECULOSIS CLINICAL  CLASSIFICATION  OF TUBECULOSIS
CLINICAL CLASSIFICATION OF TUBECULOSIS
 
Sarcoidosis
Sarcoidosis Sarcoidosis
Sarcoidosis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Human Immunodeficiency Viru Sreal
Human Immunodeficiency Viru SrealHuman Immunodeficiency Viru Sreal
Human Immunodeficiency Viru Sreal
 
Pharmacotherapy of Tuberculosis
Pharmacotherapy of TuberculosisPharmacotherapy of Tuberculosis
Pharmacotherapy of Tuberculosis
 
Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
TB and sarcoidosis.pptx
TB and sarcoidosis.pptxTB and sarcoidosis.pptx
TB and sarcoidosis.pptx
 

More from SaheedAbdulbasit

Climate change and microbiota-1.pptx
Climate change and microbiota-1.pptxClimate change and microbiota-1.pptx
Climate change and microbiota-1.pptx
SaheedAbdulbasit
 
ADESANMI OLOLADE AFEGESE (21HSE074).pptx
ADESANMI OLOLADE AFEGESE (21HSE074).pptxADESANMI OLOLADE AFEGESE (21HSE074).pptx
ADESANMI OLOLADE AFEGESE (21HSE074).pptx
SaheedAbdulbasit
 
Olalere Nafisat Folake (20HSM005).pptx
Olalere Nafisat Folake (20HSM005).pptxOlalere Nafisat Folake (20HSM005).pptx
Olalere Nafisat Folake (20HSM005).pptx
SaheedAbdulbasit
 
Adeniran Ganiyat Abiodun (20HSM006).pptx
Adeniran Ganiyat Abiodun (20HSM006).pptxAdeniran Ganiyat Abiodun (20HSM006).pptx
Adeniran Ganiyat Abiodun (20HSM006).pptx
SaheedAbdulbasit
 
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptxADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
SaheedAbdulbasit
 
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.pptBABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
SaheedAbdulbasit
 
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTXAZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
SaheedAbdulbasit
 
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptxA REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
SaheedAbdulbasit
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
SaheedAbdulbasit
 
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
SaheedAbdulbasit
 
ECONOMIC IMPACT OF COVID 19.PPTX
ECONOMIC IMPACT OF COVID 19.PPTXECONOMIC IMPACT OF COVID 19.PPTX
ECONOMIC IMPACT OF COVID 19.PPTX
SaheedAbdulbasit
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
SaheedAbdulbasit
 
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptxADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
SaheedAbdulbasit
 

More from SaheedAbdulbasit (13)

Climate change and microbiota-1.pptx
Climate change and microbiota-1.pptxClimate change and microbiota-1.pptx
Climate change and microbiota-1.pptx
 
ADESANMI OLOLADE AFEGESE (21HSE074).pptx
ADESANMI OLOLADE AFEGESE (21HSE074).pptxADESANMI OLOLADE AFEGESE (21HSE074).pptx
ADESANMI OLOLADE AFEGESE (21HSE074).pptx
 
Olalere Nafisat Folake (20HSM005).pptx
Olalere Nafisat Folake (20HSM005).pptxOlalere Nafisat Folake (20HSM005).pptx
Olalere Nafisat Folake (20HSM005).pptx
 
Adeniran Ganiyat Abiodun (20HSM006).pptx
Adeniran Ganiyat Abiodun (20HSM006).pptxAdeniran Ganiyat Abiodun (20HSM006).pptx
Adeniran Ganiyat Abiodun (20HSM006).pptx
 
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptxADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
ADEDOYIN OLUWAFERANMI BLESSING (20HSM003).pptx
 
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.pptBABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
BABATUNDE AFUSAT OMOLARA (20HSM080)-2.ppt
 
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTXAZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
AZEEZ OLUWATOBI REBCCA (20HSM035).PPTX
 
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptxA REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
A REVIEW OF ANTIFUNGAL ACTIVITY OF ONION OIL.pptx
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
2._covid_19_ppt_25march_ppt_with_animation_compress.pptx
 
ECONOMIC IMPACT OF COVID 19.PPTX
ECONOMIC IMPACT OF COVID 19.PPTXECONOMIC IMPACT OF COVID 19.PPTX
ECONOMIC IMPACT OF COVID 19.PPTX
 
ANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptxANTIBIOTICS RESISTANCE.pptx
ANTIBIOTICS RESISTANCE.pptx
 
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptxADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
ADEREMI ALICE ADEPEJU (M. Tuberculosis and antibiotics resistance)-1.pptx
 

Recently uploaded

Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 

Recently uploaded (20)

Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 

ADAMS SADIAT HALIMAT (20HSM033).pptx

  • 1. THE ROLE OF IMMUNE SYSTEM IN THE EPIDEMIOLOGY AND CONTROL OF TUBERCULOSIS BY ADAMS SADIAT HALIMAT 20HSM033
  • 2.  Epidemiology is the branch of medicine which deals with the incidence, distribution, and possible control of diseases and other factors relating to health.  Tuberculosis is a potentially serious infectious disease that mainly affects the lungs.
  • 3. 19th century peak incidence in western Europe and North America 1882 - M. tuberculosis identificated by Koch 1920 - „sanatorium regimen“, collapse therapy, thoracoplasty 1960 - chemotherapy Introduction
  • 4. • acid (alcohol, alkalis) fasteness • slow rate of growth • sensitive to heat and UV irradiation • nonmotile • nonsporulating
  • 5. 1. Ischaemic heart disease 7.2 12.2 2. Cerebrovascular disease 5.7 9.7 3. Lower respiratory infections 4.2 7.1 4. COPD 3.0 5.1 5. Diarrhoeal diseases 2.2 3.7 6. HIV/AIDS 2.0 3.5 7. Tuberculosis 1.5 2.5 8. Trachea, bronchus, lung cancers 1.3 2.3 9. Road traffic accidents 1.3 2.2 10. Prematurity and low birth weight 1.2 2.0
  • 7. Exposure • Living in the household of a tuberculosis case • Immigration from an endemic area (Asia, Latin America) • Exposure in congregate living facilities (jails, shelters, health care facilities) • Older age • Residence in higher incidence location (inner cities) Susceptibility • HIV+ & PPD > 5 mm • Drug users • Close contacts of person known or suspected to have TB, sharing the same household or other enclosed enviroment & PPD > 5 mm • Documented recent converters (PPD increase > 10 mm within 2 years for those under age 35 or > 15 mm - 35 years old and over) • Medical risk factors (+PPD > 10 mm): – silicosis – weight of 10% or more below ideal body weight – chronic renal failure – diabetes mellitus – prolonged corticosteroid therapy – Persons from areas with high TB prevalence < 35 years old + PPD > 10 mm – Any skin test reactor less than 15 years old (PPD > 10 mm) Epidemiology
  • 8. Group Annual risk of TB HIV 3-10% 2-5% 2-4% PPD Converters Abnormal CXR Diabetes mellitus 0,3% No risk factor 0,01-0,1% Epidemiology
  • 9. • in patients without specific immunity • phagocytosis by alveolar macrophages • primary lesion (Ghon focus) - mid or lower lung zones • marked tendency to central liquefaction and cellular breakdown • spread through lymphatic to regional lymph nodes - marked reaction • spread into blood stream - possible settling throughout body Pathogenesis
  • 10. lipoarabinomannan complement receptor phagosome •inhibition of Ca2+ signals •blockage of recruitment and assembly of fusion mediating proteins transport to lymph nodes dissemination by blood stream Primary infection AM lysosome mannose receptor
  • 11. • Cough • Sputum (mucoid, mucopurulent) • Haemoptysis • Chest pain (pleural involvement, mediastinal lymph nodes enlargement) Clinical manifestation
  • 12. • Fever (active, progressive disease, inverse temperature chart) • Night sweats • Loss of appetite, weight loss • Other symptoms: amenorhea, stool disturbances, hoarseness, arrhytmias, erythema nodosum, phlyctenular conjuctivitis… Clinical manifestation
  • 13. 1. Ensure proper ventilation of the patients 2. Cover the mouth while sneezing or coughing 3. Taking prescribed medicines – keep regular follow up with the doctor 4. Report any side effects of the medicines
  • 14. The study demonstrated role of immune system in epidemiology and tuberculosis infection control, Tuberculosis remains one of the most deadly infectious diseases and has claimed millions of lives for many years. While significant progress has been made towards controlling the global burden of TB over the past decade, more efforts are still needed. Emerging issues such as multi drug-resistance threatens to revert the progress made regarding TB care and control